1-9 of 9
Irum Khan, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hematologic Predictors of Outcomes in Patients Undergoing Intensive Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia

Saad Arain, MD, Eshana Shah, MD, Betul Gok Yavuz, MD PhD, Sarah Stettner, Gregory Sampang Calip, PharmD,MPH,PhD, Irum Khan, MD, Pritesh Patel, MB, ChB, John G. Quigley
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-136708
Published: 2020
Journal Articles

The Role of Structural Violence in Acute Myeloid Leukemia Outcomes

Ivy Abraham, MD, Garth Rauscher, PhD MPH, Anand Ashwin Patel, MD, William B Pearse, MD, Priya Rajakumar, MD, Stephanie Berg, DO, Ahmed Aleem, MD, Ami Dave, MD, Sushma Bharadwaj, MD, Koosha Paydary, MD, Maria Acevedo-Mendez, Richard Gomez, Kylie Carlson, Stephanie B. Tsai, MD MS, Jessica K. Altman, MD, Wendy Stock, MD, John G. Quigley, Maryam Zia, MD, Melissa C. Larson, MD, Irum Khan, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10.
https://doi.org/10.1182/blood-2020-136379
Published: 2020
Journal Articles

Role of Racial, Demographic and Socioeconomic Disparities in Treatment Patterns and Outcomes in AML

Ivy Abraham, MD, Garth Rauscher, PhD MPH, Anand Ashwin Patel, MD, Wendy Stock, MD, Maryam Zia, MD, Sushma Bharadwaj, MD, Koosha Paydary, MD, Maria Acevedo-Mendez, John P Galvin, MDMS,MPH, William Pearse, MD, Jessica K. Altman, John G. Quigley, Priya Rajakumar, MD, Melissa L. Larson, MD, Irum Khan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3413.
https://doi.org/10.1182/blood-2019-124974
Published: 2019
Journal Articles

An Open-Label, Phase 2 Study of KRT-232, a First-in-Class, Oral Small Molecule Inhibitor of MDM2, for the Treatment of Patients with Myelofibrosis (MF) Who Have Previously Received Treatment with a JAK Inhibitor

Regina Garcia-Delgado, MD, Donal P. McLornan, MB, BCh (Hons), MRCP, PhD FRCPath, László Rejtő, Eric Jourdan, MD, Haifa Kathrin Al-Ali, MD, Andrzej Pluta, MD, Marek Hus, MD PhD, Joanne Ewing, PhDBMBS BSc FRPATH, Irum Khan, MD, Holger Hebart, Philipp J. Jost, MD, Sebastian Grosicki, MD PhD, Wayne M. Rothbaum, Jesse McGreivy, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2945.
https://doi.org/10.1182/blood-2019-123836
Published: 2019
Journal Articles

Inhibition of FOXM1 By Ixazomib Confers Chemosensitivity in NPM1-Wild Type Acute Myeloid Leukemia

Irum Khan, MD, Andrei Gartel, PhD, Marianna Halasi, PhD
Journal: Blood
Blood (2016) 128 (22): 1577.
https://doi.org/10.1182/blood.V128.22.1577.1577
Published: 2016
Journal Articles

A Prospective Study of IV Pentamidine for Pneumocystis Jirovecii Pneumonia Prophylaxis in Adult Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplant or Chemotherapy

Jennifer Anderson, PharmD, Scott Wirth, PharmD, Pritesh R. Patel, MD, John G. Quigley, MD, Annie L. Oh, MD, Christina Mactal-Haaf, PharmD, Irum Khan, MD, Damiano Rondelli, MD, Karen Sweiss, PharmD
Journal: Blood
Blood (2016) 128 (22): 2207.
https://doi.org/10.1182/blood.V128.22.2207.2207
Published: 2016
Journal Articles

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Karen Sweiss, PharmD, John G. Quigley, MD, Santosh L. Saraf, MD, Irum Khan, MD, Eileen D. Hacker, PhD APN, AOCN, Nadim Mahmud, MD PhD, David J. Peace, MD, Howard Ozer, MD PhD, Jennifer Windhorst, APN, Ralph R Weichselbaum, MD, Damiano Rondelli, MD
Journal: Blood
Blood (2016) 128 (22): 4646.
https://doi.org/10.1182/blood.V128.22.4646.4646
Published: 2016
Journal Articles

FOXM1 Binds Nucleophosmin in AML and Confers Resistance to Chemotherapy

Irum Khan, MD, Maryam Zia, MD, Marianna Halasi, PhD, Peter Gann, MD, ScD, Sujata Gaitonde, MD FACP, Andrei Gartel, PhD
Journal: Blood
Blood (2015) 126 (23): 2467.
https://doi.org/10.1182/blood.V126.23.2467.2467
Published: 2015
Journal Articles

CCN2 - Exploring a New Biomarker in Myelofibrosis

Ardaman Shergill, MD, Santosh L. Saraf, MD, Sujata Gaitonde, MD FCAP, Damiano Rondelli, MD, Irum Khan, MD
Journal: Blood
Blood (2015) 126 (23): 4063.
https://doi.org/10.1182/blood.V126.23.4063.4063
Published: 2015